These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36647720)

  • 1. COM33 suppresses carboplatin-induced epithelial-mesenchymal transition via inhibition of Twist1 in ovarian cancer.
    Zhou Z; Jin L; Shen J; Shi W; Xu Y; Ye L; Liu J; Pan J
    Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(1):34-42. PubMed ID: 36647720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA HAL suppresses the migration and invasion of serous ovarian cancer by inhibiting EMT signaling pathway.
    Wu K; Li L; Li L; Wang D
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arborinine suppresses ovarian cancer development through inhibition of LSD1.
    Li N; Yang L; Zuo H
    Life Sci; 2022 Feb; 291():120275. PubMed ID: 34979197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDM1A/LSD1 inhibition enhances chemotherapy response in ovarian cancer.
    Chen Y; Johnson JD; Jayamohan S; He Y; Venkata PP; Jamwal D; Alejo S; Zou Y; Lai Z; Viswanadhapalli S; Vadlamudi RK; Kost E; Sareddy GR
    Mol Carcinog; 2024 Oct; 63(10):2026-2039. PubMed ID: 38990091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant SERPINE1 DNA methylation is involved in carboplatin induced epithelial-mesenchymal transition in epithelial ovarian cancer.
    Pan JX; Qu F; Wang FF; Xu J; Mu LS; Ye LY; Li JJ
    Arch Gynecol Obstet; 2017 Dec; 296(6):1145-1152. PubMed ID: 28975405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
    Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
    Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-1294 confers cisplatin resistance in ovarian Cancer cells by targeting IGF1R.
    Zhang Y; Huang S; Guo Y; Li L
    Biomed Pharmacother; 2018 Oct; 106():1357-1363. PubMed ID: 30119207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PD98059 impairs the cisplatin-resistance of ovarian cancer cells by suppressing ERK pathway and epithelial mesenchymal transition process.
    Hou L; Hou X; Wang L; Li Z; Xin B; Chen J; Gao X; Mu H
    Cancer Biomark; 2017 Dec; 21(1):187-194. PubMed ID: 29103028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forkhead Box Protein C2 Promotes Epithelial-Mesenchymal Transition, Migration and Invasion in Cisplatin-Resistant Human Ovarian Cancer Cell Line (SKOV3/CDDP).
    Li C; Ding H; Tian J; Wu L; Wang Y; Xing Y; Chen M
    Cell Physiol Biochem; 2016; 39(3):1098-110. PubMed ID: 27562816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of PADI2 prevents proliferation and epithelial-mesenchymal transition in ovarian cancer through inhibiting JAK2/STAT3 pathway in vitro and in vivo, alone or in combination with Olaparib.
    Liu L; Zhang Z; Zhang G; Wang T; Ma Y; Guo W
    J Transl Med; 2020 Sep; 18(1):357. PubMed ID: 32951601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.
    Gupta N; Xu Z; El-Sehemy A; Steed H; Fu Y
    Gynecol Oncol; 2013 Jul; 130(1):200-6. PubMed ID: 23542683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Silibinin exerts anti-cancer activity on human ovarian cancer cells by increasing apoptosis and inhibiting epithelial-mesenchymal transition (EMT).
    Maleki N; Yavari N; Ebrahimi M; Faisal Faiz A; Khosh Ravesh R; Sharbati A; Panji M; Lorian K; Gravand A; Abbasi M; Abazari O; Shafiee Mehr M; Eskandari Y
    Gene; 2022 May; 823():146275. PubMed ID: 35189245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
    Ge T; Liu T; Guo L; Chen Z; Lou G
    Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A10 silencing suppresses proliferation, migration and invasion of ovarian cancer cells and enhances sensitivity to carboplatin.
    Wang L; Yan W; Li X; Liu Z; Tian T; Chen T; Zou L; Cui Z
    J Ovarian Res; 2019 Nov; 12(1):113. PubMed ID: 31739800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways.
    Way TD; Huang JT; Chou CH; Huang CH; Yang MH; Ho CT
    Eur J Cancer; 2014 Jan; 50(2):366-78. PubMed ID: 24157255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of hsa_circ_0001681 suppresses epithelial-mesenchymal transition in thyroid carcinoma via targeting to miR-942-5p/TWIST1 signaling pathway.
    Wang T; Huang Y
    J Bioenerg Biomembr; 2021 Oct; 53(5):609-620. PubMed ID: 34164767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnesium Isoglycyrrhizinate Induces an Inhibitory Effect on Progression and Epithelial-Mesenchymal Transition of Laryngeal Cancer via the NF-κB/Twist Signaling.
    Zhang J; Zhao R; Xing D; Cao J; Guo Y; Li L; Sun Y; Tian L; Liu M
    Drug Des Devel Ther; 2020; 14():5633-5644. PubMed ID: 33376307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allicin Inhibits Proliferation and Invasion in Vitro and in Vivo via SHP-1-Mediated STAT3 Signaling in Cholangiocarcinoma.
    Chen H; Zhu B; Zhao L; Liu Y; Zhao F; Feng J; Jin Y; Sun J; Geng R; Wei Y
    Cell Physiol Biochem; 2018; 47(2):641-653. PubMed ID: 29794468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis.
    Meier JC; Haendler B; Seidel H; Groth P; Adams R; Ziegelbauer K; Kreft B; Beckmann G; Sommer A; Kopitz C
    Cancer Med; 2015 Feb; 4(2):253-67. PubMed ID: 25490861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment.
    Westfall SD; Skinner MK
    Mol Cancer Ther; 2005 Nov; 4(11):1764-71. PubMed ID: 16275998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.